PARSATUZUMAB

UNII: 435M4HCP2M
Preferred Substance Name: PARSATUZUMAB

1312797-14-0
ANTI-EGFL7 MONOCLONAL ANTIBODY
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROTEIN EGFL7 (EPIDERMAL GROWTH FACTOR-LIKE DOMAIN 7)) (HUMAN-MUS MUSCULUS MONOCLONAL MEGF0444A HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL MEGF0444A .KAPPA.-CHAIN, DIMER
MEGF0444A
MEGF-0444A
PARSATUZUMAB [INN]
PARSATUZUMAB [USAN]
PARSATUZUMAB [WHO-DD]
RG-741
RG7414
RG-7414

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

PARSATUZUMAB

Synonyms and Mappings

Resources

Note